Androgen receptor reactivation in castration-resistant prostate cancer: mechanisms, epigenetic adaptation, and therapeutic vulnerabilities - Top-Institutions - MDSpire

Androgen receptor reactivation in castration-resistant prostate cancer: mechanisms, epigenetic adaptation, and therapeutic vulnerabilities

  • By

  • Juntao Guo

  • Ke Wu

  • Zheng Ma

  • Shuai Guo

  • Fei Wang

  • Lingxiang Lu

  • May 21, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, Massachusetts

    Key Differentiators

    • Oncology
    • Urology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology
    • Urology

  • #3

    Harvard Cancer Center
    Harvard Cancer Center

    Boston, Massachusetts

    Key Differentiators

    • Oncology
    • Urology

  • #4

    University of California, San Francisco
    University of California, San Francisco

    San Francisco, California

    Key Differentiators

    • Oncology
    • Urology

  • #5

    Emory University
    Emory University

    Atlanta, Georgia

    Key Differentiators

    • Oncology
    • Urology

Original Source(s)

Androgen receptor reactivation in castration-resistant prostate cancer: mechanisms, epigenetic adaptation, and therapeutic vulnerabilities

  • by Juntao Guo, Ke Wu, Zheng Ma, Shuai Guo, Fei Wang, Lingxiang Lu

  • May 21, 2026

Related Content

Diffuse large B-cell lymphoma presenting as a scalp tumor with skull destruction and neurological symptoms: a case report

Predicting preoperative axillary lymph node metastasis to guide surgical decisions in invasive breast cancer

Treatment evolution and survival impact of consolidation therapies in mantle cell lymphoma: insights from an Asia-Pacific real-world registry